RU93004970A - Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция - Google Patents

Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция

Info

Publication number
RU93004970A
RU93004970A RU93004970/04A RU93004970A RU93004970A RU 93004970 A RU93004970 A RU 93004970A RU 93004970/04 A RU93004970/04 A RU 93004970/04A RU 93004970 A RU93004970 A RU 93004970A RU 93004970 A RU93004970 A RU 93004970A
Authority
RU
Russia
Prior art keywords
cycloalkyl
derivatives
pharmaceutical composition
substituted glutaramide
substituted
Prior art date
Application number
RU93004970/04A
Other languages
English (en)
Other versions
RU2108322C1 (ru
Inventor
Кристофер Данилевич Джон
Джеймс Кейт
Юрек Кобилеки Ричард
Original Assignee
Пфайзер Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888820844A external-priority patent/GB8820844D0/en
Application filed by Пфайзер Инк. filed Critical Пфайзер Инк.
Publication of RU93004970A publication Critical patent/RU93004970A/ru
Application granted granted Critical
Publication of RU2108322C1 publication Critical patent/RU2108322C1/ru

Links

Claims (1)

  1. Описываются циклоалкил-замещенные глутарамидные производные общей формулы
    Figure 00000001

    Описываются также фармацевтически приемлемые соли и биопредшественники указанных соединений, применение композиции на их основе.
RU93004970A 1988-09-05 1993-05-24 Производные циклоалкилзамещенного глутарамида и фармацевтическая композиция на их основе RU2108322C1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8820844.2 1988-09-05
GB888820844A GB8820844D0 (en) 1988-09-05 1988-09-05 Therapeutic agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU4614874 Division

Publications (2)

Publication Number Publication Date
RU93004970A true RU93004970A (ru) 1997-04-10
RU2108322C1 RU2108322C1 (ru) 1998-04-10

Family

ID=10643114

Family Applications (2)

Application Number Title Priority Date Filing Date
SU894614874A RU2012556C1 (ru) 1988-09-05 1989-09-04 Способ получения производных циклоалкилглутарамида или их фармацевтически приемлемых солей
RU93004970A RU2108322C1 (ru) 1988-09-05 1993-05-24 Производные циклоалкилзамещенного глутарамида и фармацевтическая композиция на их основе

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SU894614874A RU2012556C1 (ru) 1988-09-05 1989-09-04 Способ получения производных циклоалкилглутарамида или их фармацевтически приемлемых солей

Country Status (30)

Country Link
US (1) US4975444A (ru)
EP (1) EP0358398B1 (ru)
JP (1) JPH0660144B2 (ru)
CN (1) CN1031051C (ru)
AT (1) ATE86606T1 (ru)
AU (1) AU604195B2 (ru)
CA (1) CA1341046C (ru)
CY (1) CY1811A (ru)
CZ (1) CZ282142B6 (ru)
DD (1) DD284222A5 (ru)
DE (1) DE68905272T2 (ru)
DK (1) DK175082B1 (ru)
EG (1) EG18936A (ru)
ES (1) ES2054009T3 (ru)
FI (1) FI111715B (ru)
GB (1) GB8820844D0 (ru)
HK (1) HK130394A (ru)
HU (2) HU215440B (ru)
IE (1) IE62020B1 (ru)
IL (1) IL91460A (ru)
MX (1) MX17418A (ru)
MY (1) MY106606A (ru)
NO (1) NO177747C (ru)
NZ (1) NZ230550A (ru)
PH (1) PH26272A (ru)
PL (1) PL161527B1 (ru)
PT (1) PT91623B (ru)
RU (2) RU2012556C1 (ru)
YU (1) YU168489A (ru)
ZA (1) ZA896760B (ru)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8925933D0 (en) * 1989-11-16 1990-01-04 Pfizer Ltd Glutaric acid derivatives and preparation thereof
US5157138A (en) * 1989-11-16 1992-10-20 Pfizer, Inc. Glutaric acid derivatives and preparation thereof
US5260467A (en) * 1989-11-16 1993-11-09 Pfizer Inc. Glutaric acid derivatives and preparation thereof
CA2069112A1 (en) * 1989-11-21 1991-05-22 Bernard R. Neustadt Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors
GB8926512D0 (en) * 1989-11-23 1990-01-10 Pfizer Ltd Therapeutic agents
GB9004260D0 (en) * 1990-02-26 1990-04-18 Pfizer Ltd Therapeutic agents
US5166143A (en) * 1990-05-31 1992-11-24 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
FR2665440B1 (fr) * 1990-07-31 1994-02-04 Lipha Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant.
US5643921A (en) * 1990-09-26 1997-07-01 E.R. Squibb & Sons, Inc. Cardiopulmonary bypass and organ transplant using a potassium channel activator
DE4036706A1 (de) * 1990-11-17 1992-05-21 Hoechst Ag Verfahren zur behandlung der cardialen sowie der vasculaeren hypertrophie und hyperplasie
GB9103454D0 (en) * 1991-02-19 1991-04-03 Pfizer Ltd Therapeutic agents
US5298492A (en) * 1992-08-04 1994-03-29 Schering Corporation Diamino acid derivatives as antihypertensives
US5208236A (en) * 1992-09-23 1993-05-04 Schering Corporation N-(acylaminomethyl)glutaryl amino acids and use
DE69424846T2 (de) * 1993-11-16 2000-11-16 Novartis Ag Zyklische Aminosäure-Derivate mit ACE und NEP inhibierender Aktivität
GB9324931D0 (en) 1993-12-04 1994-01-26 Pfizer Ltd Glutaramide derivatives
US5512592A (en) * 1994-09-09 1996-04-30 Wake Forest University Method of producing cardiotonic effect and improving cardiac contractile function by administration of carnosine
WO1998057173A1 (en) * 1997-06-10 1998-12-17 Eli Lilly And Company Combinatorial process for preparing substituted phenylalanine libraries
EP1233013B1 (en) * 1999-11-18 2007-02-28 Ajinomoto Co., Inc. Novel phenylalanine derivatives
JP2004518679A (ja) * 2001-02-01 2004-06-24 シャイア ラボラトリーズ，インコーポレイテッド リポイドビヒクルに分散させたサムパトリラートを含む薬学的組成物
WO2002087621A1 (en) * 2001-04-30 2002-11-07 Shire Laboratories Inc. Pharmaceutical composition including ace/nep inhibitors and bioavailability enhancers
US7160859B2 (en) * 2002-10-11 2007-01-09 University Of Medicine & Dentistry Of New Jersey Mst1 modulation of apoptosis in cardiac tissue and modulators of Mst1 for treatment and prevention of cardiac disease
US7045653B2 (en) 2002-12-23 2006-05-16 Pfizer, Inc. Pharmaceuticals
GB0230036D0 (en) * 2002-12-23 2003-01-29 Pfizer Ltd Novel pharmaceuticals
GB0230025D0 (en) * 2002-12-23 2003-01-29 Pfizer Ltd Novel pharmaceuticals
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
EP2434895A4 (en) 2009-05-13 2013-08-07 Intra Cellular Therapies Inc ORGANIC CONNECTIONS
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
DK2651896T3 (en) 2010-12-15 2015-10-05 Theravance Biopharma R & D Ip Llc Neprilysininhibitorer
NZ611528A (en) 2010-12-15 2015-06-26 Theravance Biopharma R & D Ip Llc Neprilysin inhibitors
WO2012154249A1 (en) 2011-02-17 2012-11-15 Theravance, Inc. Substituted aminobutyric derivatives as neprilysin inhibitors
KR101854874B1 (ko) 2011-02-17 2018-05-04 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 네프릴리신 억제제로서 치환된 아미노부티릭 유도체
JP5959075B2 (ja) 2011-05-31 2016-08-02 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー ネプリライシン阻害剤
ES2642883T3 (es) 2011-05-31 2017-11-20 Theravance Biopharma R&D Ip, Llc Inhibidores de neprilisina
CA2835216A1 (en) 2011-05-31 2012-12-06 Theravance, Inc. Neprilysin inhibitors
TWI560172B (en) 2011-11-02 2016-12-01 Theravance Biopharma R&D Ip Llc Neprilysin inhibitors
WO2013181332A1 (en) 2012-05-31 2013-12-05 Theravance, Inc. Nitric oxide donor neprilysin inhibitors
ES2710932T3 (es) 2012-06-08 2019-04-29 Theravance Biopharma R&D Ip Llc Inhibidores de neprilisina
SI2864292T1 (sl) 2012-06-08 2017-07-31 Theravance Biopharma R&D Ip, Llc Inhibitorji neprilizina
NZ704741A (en) 2012-08-08 2017-10-27 Theravance Biopharma R&D Ip Llc Neprilysin inhibitors
US9801882B2 (en) 2013-02-17 2017-10-31 Intra-Cellular Therapies, Inc. Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseases
ES2634218T3 (es) 2013-03-05 2017-09-27 Theravance Biopharma R&D Ip, Llc Inhibidores de neprilisina
MX2016009759A (es) 2014-01-30 2016-11-17 Theravance Biopharma R&D Ip Llc Inhibidores de neprilisina.
MX2016009760A (es) 2014-01-30 2016-11-08 Theravance Biopharma R&D Ip Llc Inhibidores de neprilisina.
EP3177627B1 (en) 2014-08-07 2019-07-24 Intra-Cellular Therapies, Inc. Imidazo[1,2-a]-pyrazolo[4,3-e]-pyrimidin-4-one derivatives with pde1 inhibiting activity
JP6766055B2 (ja) 2015-02-11 2020-10-07 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー ネプリライシン阻害剤としての（２ｓ，４ｒ）−５−（５’−クロロ−２’−フルオロビフェニル−４−イル）−４−（エトキシオキサリルアミノ）−２−ヒドロキシメチル−２−メチルペンタン酸
ES2857101T3 (es) 2015-02-19 2021-09-28 Theravance Biopharma R&D Ip Llc Acido (2R,4R)-5-(5’-cloro-2’-fluorobifenil-4-il)-2-hidroxi-4-[(5-metiloxazol-2-carbonil)amino]pentanoico
PT3408260T (pt) 2016-03-08 2021-07-23 Theravance Biopharma R&D Ip Llc Ácido (2s,4r)-5-(5¿-cloro-2¿-fluoro-[1,1¿-bifenil]-4-il)-2- (etoximetil)-4-(3-hidroxi-isoxazole-5-carboxamido)-2- metilpentanoico cristalino e suas utilizações
US10682354B2 (en) 2016-03-28 2020-06-16 Intra-Cellular Therapies, Inc. Compositions and methods
EP3746081A4 (en) 2018-01-31 2021-10-27 Intra-Cellular Therapies, Inc. INNOVATIVE USES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0103077B1 (en) * 1982-06-17 1988-05-18 Schering Corporation Substituted dipeptides, methods for their production, pharmaceutical compositions containing them, method for making such pharmaceutical compositions
EP0185079B1 (en) * 1984-06-08 1988-10-19 Ciba-Geigy Ag N-substituted butyramide derivatives
EP0225292A3 (en) * 1985-12-06 1988-11-30 Ciba-Geigy Ag Certain n-substituted butyramide derivatives
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제
GB8811873D0 (en) * 1988-05-19 1988-06-22 Pfizer Ltd Therapeutic agents
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents

Similar Documents

Publication Publication Date Title
RU93004970A (ru) Производные циклоалкилзамещенного глутарамида, их применение, фармацевтическая композиция
RU93055882A (ru) Производные n-сульфонил-2-оксоиндола, способ их получения, исходные для их получения, фармацевтическая композиция на их основе
RU92004593A (ru) Производные гетероциклилметил-хромана в виде смеси изомеров или отдельных изомеров или их соли, способ их получения и лекарственное средство
IT8821324A0 (it) Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose.
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
RU92004562A (ru) Новые цефалоспорины, имеющие в положении 7 замещенный оксииминный радикал, метод их получения и их использование в качестве медикаментов, фармацевтический состав на их основе
DK319785A (da) Acetyleniske phenoxypropanolderivater
EP0347749A3 (en) Pyrazoloacridone derivatives with anti-tumoral activity
RU94021365A (ru) Производные метилпиперазиназепина, способ их получения, фармацевтическая композиция на их основе и использование производных в качестве фармацевтически активного вещества
IT1218322B (it) Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche
RU93047049A (ru) Новые производные фосфолипидов
IT8219486A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT8821570A0 (it) Impiego di derivati adenosinici per la preparazione di composizioni farmaceutiche aventi attivita' immunostimolante.
RU93046324A (ru) Производное 21-хлорпрегнана, способ его получения, фармкомпозиция на его основе, способ его получения
RU93004708A (ru) Производные замещенного пирролидина и их терапевтически приемлемые соли, способ их получения и фармацевтическая композиция
RU93004972A (ru) Трополоновые производные и фармацевтическая композиция для предотвращения и лечения ишемических болезней
RU93047670A (ru) Соединения общей формулы, способы их получения, фармацевтическая композиция и пестициды на их основе
IT8820927A0 (it) Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8721158A0 (it) Composto ad attivita'antiinfiammatoria, procedimento per la sua preparazione e relative composizioni farmaceutiche.
RU93050376A (ru) Полиэтилен гликолевые соединения интерферона
IT8219043A0 (it) Nuovo composto farmacologicamente attivo, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8219455A0 (it) Composto ad attivita'analgesica, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
IT8219456A0 (it) Composto ad attivita'analgesica e antiinfiammatoria ad azione protratta, procedimento per la sua preparazione e relative composizioni farmaceutiche.
IT8221552A0 (it) Nuovi composti ad attivita'antineoplastica, procedimetno per la loro preparazione e relative composizioni farmaceutiche.